1. Assessment of potentially abuse-related events in two phase 3 studies of NKTR-181, a novel opioid analgesic, using the MADDERS® system (Misuse, Abuse, and Diversion Drug Event Reporting System). (2nd September 2019) Authors: Lanier, Ryan K.; Henningfield, Jack E.; Gudin, Jeffrey; Rauck, Richard; Elder, Harrison; Erpelding, Nathalie; Treister, Roi; Gimbel, Joseph; Tagliaferri, Mary; Doberstein, Stephen K.; Di Fonzo, Carlo J.; Lu, Lin; Siddhanti, Suresh; Katz, Nathaniel P. Journal: Current medical research and opinion Issue: Volume 35:Number 9(2019) Page Start: 1513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human Abuse Potential of Oral NKTR-181 in Recreational Opioid Users: A Randomized, Double-Blind, Crossover Study. Issue 2 (25th September 2019) Authors: Ge, Xue; Henningfield, Jack E; Siddhanti, Suresh; Jobes, Janet; Lu, Lin; Xie, Sunny; Ziola, Margaret; Kelsh, Debra; Vince, Bradley; Di Fonzo, Carlo J; Tagliaferri, Mary; Zalevsky, Jonathan; Doberstein, Stephen K; Hoch, Ute; Eldon, Michael A Journal: Pain medicine Issue: Volume 21:Issue 2(2020) Page Start: e114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone. Issue 2 (10th March 2017) Authors: Webster, Lynn; Henningfield, Jack; Buchhalter, August R; Siddhanti, Suresh; Lu, Lin; Odinecs, Aleksandrs; Di Fonzo, Carlo J; Eldon, Michael A Journal: Pain medicine Issue: Volume 19:Issue 2(2018) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS). Issue 7 (30th July 2019) Authors: Gudin, Jeffrey; Rauck, Richard; Argoff, Charles; Agaiby, Eva; Gimbel, Joseph; Katz, Nathaniel; Doberstein, Stephen K; Tagliaferri, Mary; Tagliaferri, Margit; Potts, Jeffrey; Wild, James; Lu, Lin; Siddhanti, Suresh; Hale, Martin; Markman, John Journal: Pain medicine Issue: Volume 21:Issue 7(2020) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain. Issue 8 (9th March 2020) Authors: Henningfield, Jack E; Gudin, Jeffrey; Rauck, Richard; Gimbel, Joseph; Tagliaferri, Mary; Doberstein, Stephen K; Di Fonzo, Carlo; Lu, Lin; Katz, Nathaniel; Siddhanti, Suresh; Schnoll, Sidney Journal: Pain medicine Issue: Volume 21:Issue 8(2020) Page Start: 1553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0195 SELECTIVE EXPANSION OF REGULATORY T-CELLS IN HUMANS BY A NOVEL IL-2 CONJUGATE T-REG STIMULATOR, NKTR-358, BEING DEVELOPED FOR THE TREATMENT OF AUTOIMMUNE DISEASES. (June 2019) Authors: Fanton, Christie; Siddhanti, Suresh; Dixit, Neha; Lu, Lin; Gordi, Toufigh; Dickerson, Daniel; Zalevsky, Jonathan; Kotzin, Brian Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back pain. Issue 6 (June 2019) Authors: Markman, John; Gudin, Jeffrey; Rauck, Richard; Argoff, Charles; Rowbotham, Michael; Agaiby, Eva; Gimbel, Joseph; Katz, Nathaniel; Doberstein, Stephen K.; Tagliaferri, Mary; Lu, Lin; Siddhanti, Suresh; Hale, Martin Journal: Pain Issue: Volume 160:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗